Effects of rosiglitazone on blood glucose, blood lipid and vascular remodeling in rats fed with high-fructose diet

Chinese Pharmacological Bulletin

Volumn 20, Issue 5, 2004, Pages 571-575

  Wen, Jin Sheng ^a   Hu, Bi ^a   Long, Guang ^a   Duan, Zhi Liang ^a   Ling, Hong Yan ^a   Zhou, Shou Hong ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Fructose; Hypertension; Rosiglitazone; Vascular remodeling

Indexed keywords

CHOLESTEROL; FRUCTOSE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSIGLITAZONE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTERY DIAMETER; ARTERY MEDIA; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD SAMPLING; CONTROLLED STUDY; DIETARY INTAKE; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MALE; MESENTERIC ARTERY; NONHUMAN; PARAMETER; RAT; TISSUE FIXATION; TISSUE REPAIR;

EID: 4043145785     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Schoon jans K, Martin G, Staels B et al. Peroxisome proliferator- activated recepors, orphans with ligands and functions. Curr opin Lipidol, 1997; 8(3): 159-66
2. Iglarz M, Touyz RM, Amiri F et al. Effect of peroxisome proliferator-activated receptor-alpha and-gamma activators on vascular remodeling in endothelin-dependent hypertension. Arterioscler Thromb Vasc Biol, 2003; 23(1): 45-51
3. Raji A, Seely EW, Bekins SA et al. Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients. Diabetes Care, 2003; 26(1): 172-8
4. Diep QN, El Mabrouk M, Cohn JS et al. Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: Role of peroxisome proliferator-activated receptor-gamma. Circulation, 2002; 105(19): 2296-302
5. Walker AB, Chattington PD, Buckingham RE et al. The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats. The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats. Diabetes, 1999; 48(7): 1448-53
6. Fukunaga Y, Itoh H, Doi K et al. Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides. Atherosclerosis, 2001; 158(1): 113-9
7. Law RE, Goetz S, Xi XP et al. Expression and function of PPAR-γ in rat and human vascular smooth muscle cells. Circulation, 2000; 101(11): 1311-8
8. Marx N, Schonbeck U, Lazar MA et al. Peroxisomeproliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. Circ Res, 1998; 83(11): 1097-103
9. Reaven GM, Ho H. Sugar-induced hypertension in Sprague-Dawley rats. Am J Hypertens, 1991; 4(7 Pt 1): 610-4
10. Mulvany MJ, Baumbach GL, Aalkjaer C et al. Vascular remodeling. Hypertension, 1996; 28(3): 505-6
11. Cong LN, Chen H, Li Y et al. Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells. Mol Endocrinol. 1997; 11(13); 1881-90
12. Sasaoka T, Ishiki M, Sawa T et al. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signalling pathways. Endocrinology. 1996; 137(10): 4427-34
13. Wakino S, Kintscher U, Kim S et al. Peroxisome proliferator-activated receptor-γ ligands inhibit Rb phosphorylation and G13S transition in vascular smooth muscle cells. J Biol Chem, 2000; 275(29): 22435-41